Time to leave rigid traditions in Type 1 diabetes research.

Suppr

超能文献

作者信息

Ludvigsson Johnny

机构信息

Division of Pediatrics, Department of Clinical & Experimental Medicine, Linköping University, Sweden.

出版信息

Immunotherapy. 2017 Jun;9(8):619-621. doi: 10.2217/imt-2017-0050.

DOI:10.2217/imt-2017-0050

PMID:28653568

Abstract

摘要

相似文献

Time to leave rigid traditions in Type 1 diabetes research.

Immunotherapy. 2017 Jun;9(8):619-621. doi: 10.2217/imt-2017-0050.

Dreams for type 1 diabetes: shutting off autoimmunity and stimulating beta-cell regeneration.1型糖尿病的梦想：关闭自身免疫并刺激β细胞再生。

Endocrinology. 2010 Jul;151(7):2971-3. doi: 10.1210/en.2010-0538.

Dipeptidyl peptidase-4 inhibitors (DPP-4i) combined with vitamin D3: An exploration to treat new-onset type 1 diabetes mellitus and latent autoimmune diabetes in adults in the future.二肽基肽酶-4 抑制剂（DPP-4i）联合维生素 D3：探索未来治疗成人新发 1 型糖尿病和成人隐匿性自身免疫性糖尿病的方法。

Int Immunopharmacol. 2018 Apr;57:11-17. doi: 10.1016/j.intimp.2018.02.003. Epub 2018 Feb 22.

Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells.糖尿病的治疗策略：胰腺β细胞的免疫调节。

Front Endocrinol (Lausanne). 2021 Aug 17;12:716692. doi: 10.3389/fendo.2021.716692. eCollection 2021.

Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.通过辅助免疫疗法上调糖尿病NOD小鼠胰腺淋巴结中的CD4+CD25+FOXP3+调节性T细胞。

Transplantation. 2009 Jan 27;87(2):198-206. doi: 10.1097/TP.0b013e3181933261.

Immunotherapy in type 1 diabetes: a shorter but more winding road?1型糖尿病的免疫治疗：道路更短却更加曲折？

Diabetes. 2012 Sep;61(9):2214-5. doi: 10.2337/db12-0648.

Science Signaling Podcast for 21 June 2016: Nanoparticles to treat type 1 diabetes.2016年6月21日《科学信号》播客：用于治疗1型糖尿病的纳米颗粒

Sci Signal. 2016 Jun 21;9(433):c15. doi: 10.1126/scisignal.aag2900.

[Cellular immunity in diabetes mellitus].

Rev Clin Esp. 1984;174(1-2):7-11.

The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes.DPP-4 抑制剂的新见解：它们在自身免疫性糖尿病中的潜在免疫调节功能。

Diabetes Metab Res Rev. 2014 Nov;30(8):646-53. doi: 10.1002/dmrr.2530.

The convergence of type 1 and type 2 diabetes in childhood: the accelerator hypothesis.儿童 1 型和 2 型糖尿病的融合：加速器假说。

Pediatr Diabetes. 2012 Jun;13(4):334-9. doi: 10.1111/j.1399-5448.2011.00831.x. Epub 2011 Nov 8.

引用本文的文献

Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial.淋巴内注射谷氨酸脱羧酶-明矾再给药治疗1型糖尿病：DIAGNODE-B试点试验

Int J Mol Sci. 2025 Jan 4;26(1):374. doi: 10.3390/ijms26010374.

Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype.在 1 型糖尿病患者中进行淋巴内谷氨酸脱羧酶给药，在具有 DR3DQ2 单体型的患者中诱导出独特的早期免疫反应。

Front Immunol. 2023 Feb 2;14:1112570. doi: 10.3389/fimmu.2023.1112570. eCollection 2023.

Determination of autoantibodies in type 2 diabetes: one simple way to improve classification.2 型糖尿病自身抗体的测定：一种简单的分类改善方法。

Diabetologia. 2023 May;66(5):955-957. doi: 10.1007/s00125-022-05858-4. Epub 2023 Jan 11.

Diabetes: Concepts of β-Cell Organ Dysfunction and Failure Would Lead to Earlier Diagnoses and Prevention.糖尿病：β 细胞功能障碍和衰竭概念将导致更早的诊断和预防。

Diabetes. 2021 Nov;70(11):2444-2456. doi: 10.2337/dbi21-0012.

Combined vitamin D, ibuprofen and glutamic acid decarboxylase-alum treatment in recent onset Type I diabetes: lessons from the DIABGAD randomized pilot trial.联合维生素D、布洛芬和谷氨酸脱羧酶-明矾治疗近期发病的1型糖尿病：DIABGAD随机先导试验的经验教训

Future Sci OA. 2020 Jun 23;6(7):FSO604. doi: 10.2144/fsoa-2020-0078.

Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route.1 型糖尿病的自身抗原治疗：选择自身抗原和给药途径的未解问题。

Int J Mol Sci. 2020 Feb 26;21(5):1598. doi: 10.3390/ijms21051598.

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.引入表型概念以应对 1 型糖尿病疾病异质性的挑战。

Diabetes Care. 2020 Jan;43(1):5-12. doi: 10.2337/dc19-0880. Epub 2019 Nov 21.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验